YUMANITY THERAPEUTICS INC (YMTX) Earnings History & Surprises

NASDAQ:YMTX • US98872L1026

Current stock price

1.89 USD
+0.15 (+8.62%)
At close:
1.9 USD
+0.01 (+0.53%)
After Hours:

YMTX Earnings overview

Past quarterly earnings results for YUMANITY THERAPEUTICS INC (YMTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 22, 2023
Period
Q4 / 2022
EPS Estimate
-$1.17
Revenue Estimate
3.06M

Last Reported

Most Recent
Release Date
N/A
Period
Q3 / 2022
EPS Reported
-$0.31
EPS Surprise
71.86%
Revenue Surprise
-45.02%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2022 -0.31 -1.10 71.86% 68.04% 1.402M 2.55M -45.02% -14.25%
Q2 2022 -0.45 -1.01 55.44% 56.31% 1.657M 2.55M -35.02% -21.62%
Q1 2022 -0.88 -0.97 9.18% -3.53% 1.023M 2.04M -49.85% -71.02%
Q4 2021 -1.00 -1.07 6.92% -125.25% 762K 1.842M -58.63% -88.96%
Q3 2021 -0.97 -1.15 15.84% 55.91% 1.635M 1.972M -17.09% -
Q2 2021 -1.03 -0.86 -20.21% 69.71% 2.114M 2.312M -8.56% -
Q1 2021 -0.85 -0.85 -0.40% 77.63% 3.53M 2.311M 52.75% -
Q4 2020 3.96 -2.86 238.66% - 6.9M - -
Q3 2020 -2.20 -3.67 40.09% - - -
Q2 2020 -3.40 -4.34 21.57% - 127.5K -100.00% -
Q1 2020 -3.80 -5.20 26.95% - 306K -100.00% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

YMTX EPS Q2Q GrowthYMTX EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 -100 -200 -300

Revenue Historical Q2Q growth and Acceleration

YMTX Revenue Q2Q GrowthYMTX Revenue Q2Q GrowthRevenue Q2Q Growth Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 100 200 300

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
35.85%
Max EPS beat (4)
71.86%
Min EPS beat (4)
6.92%

Revenue beat statistics

Revenue beat (4)
0
Average Revenue beat (4)
-47.13%
Max Revenue beat (4)
-35.02%
Min Revenue beat (4)
-58.63%

Analysis

In the last 4 quarters, YMTX has consistently beaten EPS estimates in all releases
YMTX has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, YMTX has beaten the EPS estimates by 35.9% on average.
In the last 4 quarters, YMTX reported -47.1% below the revenue estimates on average.
YMTX Overview YMTX Technical Analysis Report YMTX Fundamental Analysis Report YMTX Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

YUMANITY THERAPEUTICS INC / YMTX Earnings FAQ

Did YMTX stock beat earnings estimates in the most recent quarter?

YUMANITY THERAPEUTICS INC (YMTX) beat EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does YMTX stock beat earnings estimates?

In the last 4 quarters, YUMANITY THERAPEUTICS INC (YMTX) has beaten EPS estimates in 4 out of 4 releases.